Physician

Bradley T Sumrall, MD

According to 2025 Medicare claims, Bradley Sumrall, MD (NPI: 1679689301) practices hematology/oncology in the Warner Robins, GA market, with the plurality of this provider's patient population coming from Houston, GA. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 31088-9998. Sumrall is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Sumrall's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,578 traditional Medicare patients, billed 285,918 HCPCS/CPT codes, and received $5,291,718 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,320 prescription claims across 537 beneficiaries totaling $4,354,552 in drug costs, led by Xtandi (Enzalutamide). DME data shows 44 claims. Open Payments data shows 74 records totaling $20,765. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,738,218 to $5,291,718. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,324,822 to $4,354,552. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $8,108 to $1,102.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	973	120,676	$1,738,218
2016	996	113,013	$1,879,436
2017	1,104	141,911	$2,253,765
2018	1,257	176,040	$2,917,277
2019	1,504	258,889	$4,385,735
2020	1,560	297,154	$5,075,924
2021	1,613	327,682	$5,777,886
2022	1,560	281,590	$4,841,376
2023	1,564	279,367	$4,946,027
2024	1,578	285,918	$5,291,718

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	245	1,499	$1,324,822
2016	240	1,425	$1,283,622
2017	260	1,289	$866,632
2018	311	1,500	$982,831
2019	365	1,749	$1,782,437
2020	319	1,565	$1,911,542
2021	375	1,831	$2,422,151
2022	381	1,930	$3,490,056
2023	448	2,205	$3,529,800
2024	537	2,320	$4,354,552

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	49	205	$26,587
2016	11	90	$10,184
2017	N/R	29	$257
2018	14	115	$6,733
2019	30	147	$4,849
2020	30	211	$6,735
2021	18	186	$4,972
2022	25	110	$2,397
2023	26	84	$3,639
2024	N/R	44	$4,783

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	877	1,498	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	429	504	$64
82728	Ferritin (blood protein) level	441	612	$13
80053	Blood test, comprehensive group of blood chemicals	950	2,046	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,130	2,685	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	71	2,190	$1,045,592
Pomalyst	Pomalidomide	21	588	$480,336
Cabometyx	Cabozantinib S-Malate	15	450	$364,440
Tagrisso	Osimertinib Mesylate	19	630	$345,571
Revlimid	Lenalidomide	13	364	$230,402

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$4,256
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$263
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	18	$263

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	72	$1,649	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$19,116	Mirati Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bradley T. Sumrall, MD?

Tedicare shows public-source Medicare data for Bradley T. Sumrall, MD (NPI 1679689301), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bradley T. Sumrall, MD have ACO affiliation data?

Bradley T. Sumrall, MD is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Bradley T. Sumrall, MD?

Bradley T. Sumrall, MD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Bradley T. Sumrall, MD have Open Payments data?

Bradley T. Sumrall, MD has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.